ReviewBiomolecules2025

Linking Cardiovascular Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Role of Cardiometabolic Drugs in MASLD Treatment.

Marios Zisis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.